Please use this identifier to cite or link to this item:
https://doi.org/10.1016/j.stemcr.2021.06.004
| Title: | Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing | Authors: | Zeps, Nikolajs Lysaght, Tamra Chadwick, Ruth Erler, Alexandre Foo, Roger Giordano, Simona Lai, Poh San Schaefer, G Owen Xafis, Vicki Chew, Wei Leong Sugarman, Jeremy |
Keywords: | Science & Technology Life Sciences & Biomedicine Cell & Tissue Engineering Cell Biology METHYLATION |
Issue Date: | 13-Jul-2021 | Publisher: | CELL PRESS | Citation: | Zeps, Nikolajs, Lysaght, Tamra, Chadwick, Ruth, Erler, Alexandre, Foo, Roger, Giordano, Simona, Lai, Poh San, Schaefer, G Owen, Xafis, Vicki, Chew, Wei Leong, Sugarman, Jeremy (2021-07-13). Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing. STEM CELL REPORTS 16 (7) : 1652-1655. ScholarBank@NUS Repository. https://doi.org/10.1016/j.stemcr.2021.06.004 | Abstract: | Altering the human epigenome with gene-editing technology in attempt to treat a variety of diseases and conditions seems scientifically feasible. We explore some of the ethical and regulatory issues related to the clinical translation of human epigenetic editing arguing that such approaches should be considered akin to somatic therapies. | Source Title: | STEM CELL REPORTS | URI: | https://scholarbank.nus.edu.sg/handle/10635/228277 | ISSN: | 22136711 | DOI: | 10.1016/j.stemcr.2021.06.004 |
| Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing.pdf | 359.25 kB | Adobe PDF | OPEN | Published | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.